Sivelestat sodium attenuates acute lung injury by signaling pathways sivelestat sodium (siv) neutrophil elastase inhibitor is mainly used for the clinical treatment of acute respiratory distress syndrome (ards) or acute lung injury (ali)

HIGHLIGHTS

• who: R ESEAR CH AR and colleagues from the (UNIVERSITY) have published the article: Sivelestat sodium attenuates acute lung injury by signaling pathways Sivelestat sodium (SIV) neutrophil elastase inhibitor is mainly used for the clinical treatment of acute respiratory distress syndrome (ARDS) or acute lung injury (ALI), in the Journal: (JOURNAL) of 03/01/2023
• what: This study hypothesized that, in addition to inhibiting NE, SIV had the potential in the treatment of ALI. To test this hypothesis, this study investigated the efficacy of SIV in ALI treatment in_vitro and in_vivo and explored its effects . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.